34 related articles for article (PubMed ID: 38372300)
1. The Potential of Fecal and Urinary Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: A Systematic Review.
Arif T; Nazir F; Aurangzeb RF; Hussain M; Aurangzeb RI; Rehman A; Kumar K; Islam R; Islam H; Khalid Q; Arrey Agbor DB; Munir K; Bokhari SFH; Shehryar A; Ibrahim M
Cureus; 2024 Apr; 16(4):e59248. PubMed ID: 38813271
[TBL] [Abstract][Full Text] [Related]
2. Conditional reprogramming: next generation cell culture.
Wu X; Wang S; Li M; Li J; Shen J; Zhao Y; Pang J; Wen Q; Chen M; Wei B; Kaboli PJ; Du F; Zhao Q; Cho CH; Wang Y; Xiao Z; Wu X
Acta Pharm Sin B; 2020 Aug; 10(8):1360-1381. PubMed ID: 32963937
[TBL] [Abstract][Full Text] [Related]
3. Cell Lineage Infidelity in PDAC Progression and Therapy Resistance.
Malinova A; Veghini L; Real FX; Corbo V
Front Cell Dev Biol; 2021; 9():795251. PubMed ID: 34926472
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology and pancreatic cancer management: State of the art and further perspectives.
Caputo D; Pozzi D; Farolfi T; Passa R; Coppola R; Caracciolo G
World J Gastrointest Oncol; 2021 Apr; 13(4):231-237. PubMed ID: 33889275
[TBL] [Abstract][Full Text] [Related]
5. Acinar-to-Ductal Metaplasia (ADM): On the Road to Pancreatic Intraepithelial Neoplasia (PanIN) and Pancreatic Cancer.
Marstrand-Daucé L; Lorenzo D; Chassac A; Nicole P; Couvelard A; Haumaitre C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373094
[TBL] [Abstract][Full Text] [Related]
6. Generation of Induced Pluripotent Stem Cell-Like Lines from Human Pancreatic Ductal Adenocarcinoma.
Kim J; Zaret KS
Methods Mol Biol; 2019; 1882():33-53. PubMed ID: 30378042
[TBL] [Abstract][Full Text] [Related]
7. An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression.
Kim J; Hoffman JP; Alpaugh RK; Rhim AD; Reichert M; Stanger BZ; Furth EE; Sepulveda AR; Yuan CX; Won KJ; Donahue G; Sands J; Gumbs AA; Zaret KS
Cell Rep; 2013 Jun; 3(6):2088-99. PubMed ID: 23791528
[TBL] [Abstract][Full Text] [Related]
8. Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.
Lee AYL; Dubois CL; Sarai K; Zarei S; Schaeffer DF; Sander M; Kopp JL
Gut; 2019 Mar; 68(3):487-498. PubMed ID: 29363536
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.
du Rieu MC; Torrisani J; Selves J; Al Saati T; Souque A; Dufresne M; Tsongalis GJ; Suriawinata AA; Carrère N; Buscail L; Cordelier P
Clin Chem; 2010 Apr; 56(4):603-12. PubMed ID: 20093556
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency.
Alshaikh A; Grygoryev D; Keith D; Sheppard B; Sears RC; Kim J; Soufi A
J Vis Exp; 2024 Feb; (204):. PubMed ID: 38372300
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of targeting acinar cell reprogramming in pancreatic cancer.
Wong CH; Li YJ; Chen YC
World J Gastroenterol; 2016 Aug; 22(31):7046-57. PubMed ID: 27610015
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
